Clinical trial

Bosentan in Treatment of Pulmonary Arterial Hypertension

NCT00266162

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Bosentan administration Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Bosentan in Treatment of Pulmonary Arterial Hypertension

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2004-08-01

PhasePHASE4

Conditions

Eisenmenger Syndromeverified · MONDO: Eisenmenger syndrome

Interventions

Bosentan administrationDRUG

Sponsors & collaborators

Competence Network for Congenital Heart Defectslead sponsor

German Federal Ministry of Education and Researchcollaborator

Actelioncollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00266162 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.